Trial intelligence / Profile preview

Oseltamivir for thrombocytopenia and plasma leakage in dengue

ISRCTN35227717Phase 2Completed

Sponsor
Center for Tropical and Infectious Diseases
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of oseltamivir, sponsored by Center for Tropical and Infectious Diseases. Started Jan 2018; status: completed.

02

Drugs

oseltamivir

Beyond the preview

Go deeper on ISRCTN35227717.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN35227717.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call